OSR Holdings Current Ratio 2022-2025 | OSRH
OSR Holdings current ratio from 2022 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| OSR Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.00B | $0.02B | 0.18 |
| 2025-03-31 | $0.00B | $0.01B | 0.25 |
| 2024-12-31 | $0.00B | $0.00B | 0.67 |
| 2024-09-30 | $0.00B | $0.00B | 0.01 |
| 2024-06-30 | $0.00B | $0.00B | 0.05 |
| 2024-03-31 | $0.00B | $0.00B | 0.03 |
| 2023-12-31 | $0.00B | $0.00B | 0.01 |
| 2023-09-30 | $0.00B | $0.00B | 0.08 |
| 2023-06-30 | $0.00B | $0.00B | 0.11 |
| 2023-03-31 | $0.00B | $0.00B | 1.07 |
| 2022-12-31 | $0.00B | $0.00B | 0.10 |
| 2022-09-30 | $0.00B | 0.00 | |
| 2022-06-30 | $0.00B | 0.00 | |
| 2022-03-31 | $0.00B | 0.00 | |
| 2021-12-31 | $0.00B | $0.00B | 0.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.012B | $0.000B |
| Bellevue Life Sciences Acquisition Corp. is a blank check company. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. Bellevue Life Sciences Acquisition Corp. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.160B | 27.39 |
| HCA Healthcare (HCA) | United States | $104.809B | 17.35 |
| CVS Health (CVS) | United States | $98.432B | 11.32 |
| Cencora (COR) | United States | $70.698B | 22.81 |
| Elevance Health (ELV) | United States | $67.512B | 9.90 |
| Natera (NTRA) | United States | $28.518B | 0.00 |
| DiDi Global (DIDIY) | China | $26.027B | 21.27 |
| Labcorp Holdings (LH) | United States | $21.648B | 16.51 |
| Medpace Holdings (MEDP) | United States | $16.913B | 41.99 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.316B | 0.00 |
| ICON (ICLR) | Ireland | $12.734B | 12.64 |
| Solventum (SOLV) | United States | $12.452B | 12.09 |
| CochLear (CHEOY) | Australia | $12.172B | 0.00 |
| Viatris (VTRS) | United States | $11.714B | 4.36 |
| Revvity (RVTY) | United States | $10.462B | 19.26 |
| HealthEquity (HQY) | United States | $8.601B | 34.42 |
| Charles River Laboratories (CRL) | United States | $8.316B | 16.02 |
| Avantor (AVTR) | United States | $7.841B | 11.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.997B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.872B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.054B | 36.10 |
| Bausch + Lomb (BLCO) | Canada | $5.656B | 37.14 |
| Sotera Health (SHC) | United States | $4.472B | 21.56 |
| GeneDx Holdings (WGS) | United States | $4.122B | 72.40 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| Alignment Healthcare (ALHC) | United States | $3.278B | 0.00 |
| Concentras Parent (CON) | United States | $2.469B | 15.41 |
| Premier (PINC) | United States | $2.325B | 22.54 |
| Surgery Partners (SGRY) | United States | $2.056B | 26.73 |
| Progyny (PGNY) | United States | $2.036B | 40.03 |
| Organon (OGN) | United States | $2.004B | 2.11 |
| Establishment Labs Holdings (ESTA) | $1.967B | 0.00 | |
| Ardent Health (ARDT) | United States | $1.955B | 7.55 |
| Pediatrix Medical (MD) | United States | $1.938B | 11.57 |
| PACS (PACS) | United States | $1.905B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.331B | 0.00 |
| Omada Health (OMDA) | $1.196B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.063B | 17.00 |
| CareDx (CDNA) | United States | $0.859B | 14.03 |
| Embecta (EMBC) | United States | $0.799B | 4.68 |
| InnovAge Holding (INNV) | United States | $0.685B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.668B | 9.20 |
| Nutex Health (NUTX) | United States | $0.660B | 10.00 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.551B | 0.00 |
| Pomdoctor - (POM) | China | $0.544B | 0.00 |
| Charming Medical (MCTA) | $0.466B | 0.00 | |
| So-Young (SY) | China | $0.428B | 0.00 |
| CryoPort (CYRX) | United States | $0.428B | 0.00 |
| Enhabit (EHAB) | United States | $0.401B | 18.02 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.385B | 5.78 |
| SBC Medicals (SBC) | United States | $0.355B | 7.77 |
| KindlyMD (NAKA) | United States | $0.325B | 0.00 |
| Oncology Institute (TOI) | United States | $0.310B | 0.00 |
| Agilon Health (AGL) | United States | $0.273B | 0.00 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.175B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.130B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.096B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.63 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |